These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9631063)

  • 1. Small molecule nerve growth factor analogs image receptors in vivo.
    LeSauteur L; Cheung NK; Lisbona R; Saragovi HU
    Nat Biotechnol; 1996 Sep; 14(9):1120-2. PubMed ID: 9631063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NGF induces terminal differentiation in trkA expressing neuroblastoma cells in vitro and in vivo.
    Matsushima H; Bogenmann E
    Prog Clin Biol Res; 1994; 385():177-83. PubMed ID: 7972210
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E; Peterson S; Maekawa K; Matsushima H
    Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.
    Nanduri J; Vroegop SM; Buxser SE; Neet KE
    J Neurosci Res; 1994 Mar; 37(4):433-44. PubMed ID: 7517456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor.
    Holden PH; Asopa V; Robertson AG; Clarke AR; Tyler S; Bennett GS; Brain SD; Wilcock GK; Allen SJ; Smith SK; Dawbarn D
    Nat Biotechnol; 1997 Jul; 15(7):668-72. PubMed ID: 9219271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C; Ultsch MH; Bass SH; de Vos AM
    Nature; 1999 Sep; 401(6749):184-8. PubMed ID: 10490030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurotrophins. I: Molecular features].
    Zazpe A; Del Río J
    Rev Med Univ Navarra; 1997; 41(3):173-9. PubMed ID: 10420923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
    Chen J; Zhe X
    Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational studies of conserved residues in the dimer interface of nerve growth factor.
    Guo M; Meyer SL; Kaur H; Gao JJ; Neet KE
    Protein Sci; 1996 Mar; 5(3):447-55. PubMed ID: 8868481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entering the domain of neurotrophin binding.
    Hempstead BL; Chao MV
    Nat Biotechnol; 1997 Jul; 15(7):623-4. PubMed ID: 9219261
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of nerve growth factor and its receptors in non-nervous cancer growth: efficacy of a tyrosine kinase inhibitor (AG879) and neutralizing antibodies antityrosine kinase receptor A and antinerve growth factor: an in-vitro and in-vivo study.
    Rende M; Pistilli A; Stabile AM; Terenzi A; Cattaneo A; Ugolini G; Sanna P
    Anticancer Drugs; 2006 Sep; 17(8):929-41. PubMed ID: 16940803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radioactive binding assay for inhibitors of trkA kinase.
    Knight E; Connors TJ; Maroney AC; Angeles TS; Hudkins RL; Dionne CA
    Anal Biochem; 1997 May; 247(2):376-81. PubMed ID: 9177701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors.
    Muragaki Y; Chou TT; Kaplan DR; Trojanowski JQ; Lee VM
    J Neurosci; 1997 Jan; 17(2):530-42. PubMed ID: 8987776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p75 and Trk oncoproteins expression is developmentally regulated in the inner ear of human embryos.
    Vazquez E; San José I; Naves J; Vega JA; Represa J
    Int J Dev Biol; 1996; Suppl 1():77S-78S. PubMed ID: 9087704
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinase Receptor Activation (KIRA): a rapid and accurate alternative to endpoint bioassays.
    Sadick MD
    Dev Biol Stand; 1999; 97():121-33. PubMed ID: 10463538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
    Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophins and sensory neurons: role in development, maintenance and injury. A thematic summary.
    Mendell LM
    Philos Trans R Soc Lond B Biol Sci; 1996 Mar; 351(1338):463-7. PubMed ID: 8730786
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
    Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
    Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both p140(trk) and p75(NGFR) nerve growth factor receptors mediate nerve growth factor-stimulated calcium uptake.
    Jiang H; Ulme DS; Dickens G; Chabuk A; Lavarreda M; Lazarovici P; Guroff G
    J Biol Chem; 1997 Mar; 272(11):6835-7. PubMed ID: 9054365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.